Hypercell Technologies reports $2.96 million in equity and warrant sales
The food safety diagnostics company disclosed 14 investors in an offering targeting $4.42 million.
Hypercell Technologies reported $2,958,378 sold to 14 investors in a Form D filed on October 14, 2026. The notice covers equity, options or warrants, and securities issuable on exercise or conversion.
The offering began on September 8, with $1,465,000 remaining against a $4,423,378 target. The subscribers and a named venture round stage are undisclosed.
The Ithaca company develops rapid molecular tests for food contamination and environmental monitoring. Its on-site testing approach is designed to help food processors make safety decisions without waiting for samples to travel to a central laboratory.